Filing Flows

Filing Flows › Rockwell Medical (RMTI) › Q1 2026 › vs Q4 2025

Rockwell Medical (RMTI) Q1 2026 vs Q4 2025 (quarter over quarter)

Rockwell Medical's revenue fell $1.0M (-6%) from $18.3M in Q4 2025 to $17.3M in Q1 2026.

Rockwell Medical, Q1 2026: revenue $17.3M (-8% year over year), operating margin -8.5%, net loss $1.6M, operating cash flow −$167K. The chart draws each line against Q4 2025, the increases inside each band.

Rockwell Medical: what changed, Q1 2026 vs Q4 2025Rockwell Medical: what changed, Q1 2026 vs Q4 2025Cash used in operations$2.5MWorking capital & other−$1.4MNet loss$1.1MOperating cash sources$1.1MNet loss absorbed$1.1MGeneral & admin$74KOperating costs$72KCosts & expenses$41KDepreciation & amortization−$35KInterest & other, net−$31K

Every line

LineQ1 2026Q4 2025Change%
Revenue$17.3M$18.3M−$1.0M-6%
Net loss$1.6M$554K$1.1M+190%
Costs & expenses$18.9M$18.9M$41K+0.2%
Operating costs$18.8M$18.7M$72K+0.4%
Interest & other, net$125K$156K−$31K-20%
Cost of revenue$14.4M$14.5M−$29K-0.2%
Sales & marketing$567K$540K$27K+5%
General & admin$3.8M$3.7M$74K+2%
Operating cash sources$1.6M$554K$1.1M+190%
Depreciation & amortization$511K$546K−$35K-6%
Share-based compensation$479K$457K$22K+5%
Working capital & other$448K$1.8M−$1.4M-76%
Cash used in operations$167K−$2.3M$2.5M—
Net loss absorbed$1.6M$554K$1.1M+190%

Questions

How much did Rockwell Medical's revenue grow quarter over quarter in Q1 2026?

Rockwell Medical's revenue fell $1.0M (-6%) from $18.3M in Q4 2025 to $17.3M in Q1 2026.

Q1 2026 results → · Compare in the interactive Sankey →